论文部分内容阅读
目的探讨消异方对子宫内膜异位症患者体内MCP-1和IL-6含量的影响。方法将子宫内膜异位症患者103例随机分为中药治疗组(33例)、安慰剂对照组(36例)和空白对照组(34例),比较三组治疗前后血清和在位内膜中MCP-1、IL-6含量的变化。结果中药治疗组治疗后血清和在位内膜中MCP-1和IL-6含量较用药前明显降低,而空白对照组和安慰剂对照组治疗前后血清和在位内膜中MCP-1和IL-6含量变化不明显。结论消异方能降低子宫内膜异位症患者血清和在位内膜中MCP-1和IL-6含量。
Objective To investigate the effect of Xiaoyifang on the levels of MCP-1 and IL-6 in patients with endometriosis. Methods 103 patients with endometriosis were randomly divided into the traditional Chinese medicine treatment group (33 cases), the placebo control group (36 cases) and the blank control group (34 cases). The levels of serum and eutopic endometrium In the MCP-1, IL-6 content changes. Results The levels of MCP-1 and IL-6 in serum and eutopic endometrium of Chinese medicine treatment group were significantly lower than those before treatment, while the levels of MCP-1 and IL-9 in serum and eutopic endometrium of blank control group and placebo control group -6 content change is not obvious. Conclusion Dissolution can reduce the levels of MCP-1 and IL-6 in the serum and eutopic endometrium of patients with endometriosis.